TipRanks

Sandesh Mahatme Insider Profile

4 Followers
Sandesh Mahatme, Director at Crispr Therapeutics AG, holds ― shares in Crispr Therapeutics AG (Ticker: CRSP), holds 0.00 shares in Vor Biopharma (Ticker: VOR), holds 32.27K shares in Sarepta Therapeutics (Ticker: SRPT). Most recently, Sandesh Mahatme ― shares of Crispr Therapeutics AG on ― for an estimated value of ―.
tipranks
Sandesh Mahatme

Sandesh Mahatme
Crispr Therapeutics AG (CRSP)
Director

Not Ranked
Sandesh Mahatme has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$669K
100.00%
0.00%
0.00%
0.00%
A breakdown of Sandesh Mahatme's holdings

Insider Roles

Sarepta Therapeutics
(SRPT)
EVP, CFO & CBO
Crispr Therapeutics AG
(CRSP)
Director
Vor Biopharma
(VOR)
CFO
Spyre Therapeutics
(SYRE)
Director
Roles that Sandesh Mahatme holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Sandesh Mahatme

Sandesh Mahatme's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Crispr Therapeutics AG
Director
Vor Biopharma
Dec 09, 2025
CFO
Uninformative Sell
$0.00
Sarepta Therapeutics
Jul 09, 2020
EVP, CFO & CBO
Uninformative Sell
2.26M
$668.68K
Spyre Therapeutics
Director
~FLXN
Flexion Therapeutics
Jun 12, 2020
Uninformative Buy
$41.04K
List of latest transactions for each holding click on a transaction to see Sandesh Mahatme's performance on stock

Sandesh Mahatme insider profile FAQ

What is the percentage of profitable transactions made by Sandesh Mahatme?
The percentage of profitable transactions made by Sandesh Mahatme is ―.
    What is the average return per transaction made by Sandesh Mahatme?
    The average return per transaction made by Sandesh Mahatme is ―.
      What stocks does Sandesh Mahatme hold?
      Sandesh Mahatme holds: CRSP, VOR, SRPT, SYRE, ~FLXN stocks.
        What was Sandesh Mahatme’s latest transaction?
        Sandesh Mahatme latest transaction was an Uninformative Buy of ―.
          What was Sandesh Mahatme's most profitable transaction?
          Sandesh Mahatme’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Sandesh Mahatme's role in Crispr Therapeutics AG?
            Sandesh Mahatme's role in Crispr Therapeutics AG is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.